Alistair C. Church
Queen Square
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Systemic Sclerosis-Recent Advances in Diagnosis and Management.
Journal: British journal of hospital medicine (London, England : 2005)
Published: December 24, 2025
Defining the underlying pathology of corticobasal syndrome using clinical features and biomarkers.
Journal: Brain : a journal of neurology
Published: December 15, 2025
Biomarkers of Leucine-Rich Repeat Kinase 2 (LRRK2) and Lysosomal Dysfunction in Progressive Supranuclear Palsy.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: November 24, 2025
Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UK.
Journal: BMJ open
Published: July 29, 2025
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study.
Journal: The Lancet. Neurology
Published: December 10, 2024
Evaluation of cerebrospinal fluid alpha-synuclein seed amplification assay in PSP and CBS.
Journal: medRxiv : the preprint server for health sciences
Published: March 26, 2024
Cognitive and neuropsychiatric profiles distinguish atypical parkinsonian syndromes.
Journal: Brain : a journal of neurology
Published: March 19, 2024
Evaluation of Cerebrospinal Fluid α-Synuclein Seed Amplification Assay in Progressive Supranuclear Palsy and Corticobasal Syndrome.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: February 28, 2024
Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonism.
Journal: European journal of neurology
Published: October 27, 2023
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's disease.
Journal: Nature biotechnology
Published: August 10, 2023
Last Updated: 09/26/2026